Literature DB >> 24813204

IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.

Jonathan P Huber1, Sarah R Gonzales-van Horn1, Kole T Roybal1, Michelle A Gill2, J David Farrar3.   

Abstract

CD4(+) Th2 development is regulated by the zinc finger transcription factor GATA3. Once induced by acute priming signals, such as IL-4, GATA3 poises the Th2 cytokine locus for rapid activation and establishes a positive-feedback loop that maintains elevated GATA3 expression. Type I IFN (IFN-α/β) inhibits Th2 cells by blocking the expression of GATA3 during Th2 development and in fully committed Th2 cells. In this study, we uncovered a unique mechanism by which IFN-α/β signaling represses the GATA3 gene in human Th2 cells. IFN-α/β suppressed expression of GATA3 mRNA that was transcribed from an alternative distal upstream exon (1A). This suppression was not mediated through DNA methylation, but rather by histone modifications localized to a conserved noncoding sequence (CNS-1) upstream of exon 1A. IFN-α/β treatment led to a closed conformation of CNS-1, as assessed by DNase I hypersensitivity, along with enhanced accumulation of H3K27me3 mark at this CNS region, which correlated with increased density of total nucleosomes at this putative enhancer. Consequently, accessibility of CNS-1 to GATA3 DNA binding activity was reduced in response to IFN-α/β signaling, even in the presence of IL-4. Thus, IFN-α/β disrupts the GATA3-autoactivation loop and promotes epigenetic silencing of a Th2-specific regulatory region within the GATA3 gene.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813204      PMCID: PMC4104489          DOI: 10.4049/jimmunol.1301908

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.

Authors:  Yuji Nakata; Anne C Brignier; Shenghao Jin; Yuan Shen; Stephen I Rudnick; Mayumi Sugita; Alan M Gewirtz
Journal:  Blood       Date:  2010-05-18       Impact factor: 22.113

2.  IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo.

Authors:  Fatema Z Chowdhury; Hilario J Ramos; Laurie S Davis; James Forman; J David Farrar
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

3.  Counter-regulation mechanism of IL-4 and IFN-α signal transduction through cytosolic retention of the pY-STAT6:pY-STAT2:p48 complex.

Authors:  Seol-Hee Kim; Choong-Eun Lee
Journal:  Eur J Immunol       Date:  2010-12-29       Impact factor: 5.532

4.  Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3.

Authors:  Jonathan P Huber; Hilario J Ramos; Michelle A Gill; J David Farrar
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

5.  Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates.

Authors:  Hilario J Ramos; Ann M Davis; Alexander G Cole; John D Schatzle; James Forman; J David Farrar
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

6.  Transcriptional regulation of GATA3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor.

Authors:  Eyal J Scheinman; Orly Avni
Journal:  J Biol Chem       Date:  2008-12-04       Impact factor: 5.157

7.  Chromatin environment of histone variant H3.3 revealed by quantitative imaging and genome-scale chromatin and DNA immunoprecipitation.

Authors:  Erwan Delbarre; Bente Marie Jacobsen; Andrew H Reiner; Anita L Sørensen; Thomas Küntziger; Philippe Collas
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

Review 8.  GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.

Authors:  I-Cheng Ho; Tzong-Shyuan Tai; Sung-Yun Pai
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

9.  Distinct factors control histone variant H3.3 localization at specific genomic regions.

Authors:  Aaron D Goldberg; Laura A Banaszynski; Kyung-Min Noh; Peter W Lewis; Simon J Elsaesser; Sonja Stadler; Scott Dewell; Martin Law; Xingyi Guo; Xuan Li; Duancheng Wen; Ariane Chapgier; Russell C DeKelver; Jeffrey C Miller; Ya-Li Lee; Elizabeth A Boydston; Michael C Holmes; Philip D Gregory; John M Greally; Shahin Rafii; Chingwen Yang; Peter J Scambler; David Garrick; Richard J Gibbons; Douglas R Higgs; Ileana M Cristea; Fyodor D Urnov; Deyou Zheng; C David Allis
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

10.  p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.

Authors:  B Testoni; V Schinzari; F Guerrieri; S Gerbal-Chaloin; G Blandino; M Levrero
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

View more
  16 in total

Review 1.  Interferon at the crossroads of allergy and viral infections.

Authors:  Sarah R Gonzales-van Horn; J David Farrar
Journal:  J Leukoc Biol       Date:  2015-05-29       Impact factor: 4.962

2.  Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.

Authors:  Junjun Cheng; Qiong Zhao; Yan Zhou; Liudi Tang; Muhammad Sheraz; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells.

Authors:  Sarah R Gonzales-van Horn; Leonardo D Estrada; Nicolai S C van Oers; J David Farrar
Journal:  Eur J Immunol       Date:  2016-04-08       Impact factor: 5.532

4.  Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.

Authors:  Steven D Hatfield; Keith A Daniels; Carey L O'Donnell; Stephen N Waggoner; Raymond M Welsh
Journal:  Virology       Date:  2018-04-30       Impact factor: 3.616

5.  Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants.

Authors:  Shamus P Keeler; Eugene V Agapov; Michael E Hinojosa; Adam N Letvin; Kangyun Wu; Michael J Holtzman
Journal:  J Immunol       Date:  2018-09-12       Impact factor: 5.422

6.  DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood.

Authors:  S J Barton; S Ngo; P Costello; E Garratt; S El-Heis; E Antoun; R Clarke-Harris; R Murray; T Bhatt; G Burdge; C Cooper; H Inskip; E M van der Beek; A Sheppard; K M Godfrey; K A Lillycrop
Journal:  Clin Exp Allergy       Date:  2017-08-31       Impact factor: 5.018

7.  Maternal obesity alters immune cell frequencies and responses in umbilical cord blood samples.

Authors:  Randall M Wilson; Nicole E Marshall; Daniel R Jeske; Jonathan Q Purnell; Kent Thornburg; Ilhem Messaoudi
Journal:  Pediatr Allergy Immunol       Date:  2015-06       Impact factor: 5.464

8.  Lower expression of GATA3 and T-bet correlates with downregulated IL-10 in severe falciparum malaria.

Authors:  Anusree Mahanta; Shashi Baruah
Journal:  Clin Transl Immunology       Date:  2015-11-06

9.  Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients.

Authors:  Gabriella d'Ettorre; Giancarlo Ceccarelli; Mauro Andreotti; Carla Selvaggi; Noemi Giustini; Sara Serafino; Ivan Schietroma; Giuseppe Nunnari; Guido Antonelli; Vincenzo Vullo; Carolina Scagnolari
Journal:  Mediators Inflamm       Date:  2015-06-28       Impact factor: 4.711

Review 10.  IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases.

Authors:  Henrique Borges da Silva; Raíssa Fonseca; José M Alvarez; Maria Regina D'Império Lima
Journal:  J Immunol Res       Date:  2015-10-05       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.